<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00605228</url>
  </required_header>
  <id_info>
    <org_study_id>NRL994-02/2006 (FFS)</org_study_id>
    <nct_id>NCT00605228</nct_id>
  </id_info>
  <brief_title>A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation</brief_title>
  <acronym>NORMO</acronym>
  <official_title>A Randomised, Multicentre, Single-Blind, Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norgine</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Clinical Trials Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norgine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary:

      - To demonstrate the superiority of Moviprep® versus Colopeg® in gut cleansing prior to
      colonoscopy.

      Secondary:

        -  To assess the safety of Moviprep® versus Colopeg®.

        -  To assess acceptability of Moviprep® versus Colopeg®.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary efficacy analysis will be performed on the ITT population. Secondary efficacy
      analysis will be performed on both ITT and PP sets. Results will be summarised by treatment
      and age (overall, 18-35, 36-49, 50-74 and 75-85 years old) and provided in individual data
      listings.

      Safety analysis will be performed on the safety set (ITT population). Safety data of all
      patients exposed will be summarised by treatment and age (overall, 18-35, 36-49, 50-74 and
      75-85 years old).

      Acceptability analysis will be performed on the ITT population. Acceptability data of all
      patients will be summarised by treatment and age (overall, 18-35, 36-49, 50-74 and 75-85
      years old).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the proportion of patients with successful colon cleansing as judged by blinded reviewers on the basis of videotapes recorded during the colonoscopy [the blinded reviewers will grade the colon cleansing only once]</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the proportion of patients with successful colon cleansing as judged by the colonoscopist, the colonic segment cleansing score as assessed by the colonoscopist and the blinded reviewers and Aronchick global score as assessed by blinded reviewers.</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Gastrointestinal Diseases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MOVIPREP</intervention_name>
    <description>2L Drug</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>COLOPEG</intervention_name>
    <description>4L Drug</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient's written informed consent must be obtained prior to inclusion.

          2. Male or female, outpatients between 18 and 85 years old with an indication to
             colonoscopy.

          3. Willing and able to complete the entire procedure and to comply with study
             instructions.

          4. Females of childbearing potential must employ an adequate method of birth control.

        Exclusion Criteria:

          1. Age &lt; 18 or &gt; 85 years old,

          2. Ileus,

          3. Suspected intestinal occlusion or perforation,

          4. Toxic megacolon with severe inflammation conditions of intestinal tract (patients with
             Crohn's Disease or Ulcerative Colitis included),

          5. Gastroparesis,

          6. Congestive heart failure NYHA III or IV,

          7. Documented Carcinoma or any other colic disease leading to a fragile mucosa,

          8. Documented severe renal insufficiency history

          9. Known hypersensitivity to MoviPrep®, Colopeg® or to any of their components (PEG,
             ascorbic acid etc.),

         10. Known deficiency in G6PD and/or phenylketonuria,

         11. Concurrent participation in an investigational drug/device study or participation
             within 30 days of study entry,

         12. Females who are pregnant, or planning a pregnancy. Females of child bearing potential
             not using reliable methods of birth control,

         13. Clinically significant laboratory abnormality or disease which, in the opinion of the
             investigator, will create a risk for the patient, obscure the effects of study
             treatment or interfere with study results.

         14. Vulnerable patients (protected by the law) and those admitted to a sanitary/social
             institution according to Art.L-1121-6 of the French Public Health Code.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry PONCHON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOPITAL EDOUARD HERRIOT</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Du Mans</name>
      <address>
        <city>Le Mans</city>
        <state>Lemans</state>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet de gatsro-entérologie</name>
      <address>
        <city>Anglet</city>
        <zip>64600</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet de gastroentérologie</name>
      <address>
        <city>Aubagne</city>
        <zip>13400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gastroentérologie,CENTRE HOSPITALIER d'AVIGNON</name>
      <address>
        <city>Avignon</city>
        <zip>84029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de La Châtaigneraie</name>
      <address>
        <city>Beaumont</city>
        <zip>63110</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet de gastro-entérologie</name>
      <address>
        <city>Bordeaux</city>
        <zip>33300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Martin</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gastroentérologie du Dr. Chousterman, HOPITAL INTERCOMMUNAL</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Des Maladies Du Foie Et de L'Appareil Digestif</name>
      <address>
        <city>Irigny</city>
        <zip>69540</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet de gastroentérologie</name>
      <address>
        <city>Les Sables D'olonne</city>
        <zip>85100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet Medical Jemmapes</name>
      <address>
        <city>Lille</city>
        <zip>59800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'Hépato-Gastroentérologie, CHRU NANCY, HOPITAL DE BRABOIS</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gastroentérologie, HOPITAL DE L'ARCHET</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gastro-Entérologie, HÔPITAL GEORGES POMPIDOU</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gastroentérologie du Pr. MARTEAU, HÔPITAL LARIBOISIERE</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital F. Mitterand</name>
      <address>
        <city>PAU</city>
        <zip>64000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique Courlancy</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service des Maladies de l'Appareil Digestif, Centre Hospitalier Régional et Universitaire</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gastroentérologie du Pr. LEREBOURS, HOPITAL CHARLES NICOLLE</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Jean Languedoc</name>
      <address>
        <city>Toulouse</city>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gastro-Entérologie, HOPITAL TROUSSEAU CHRU de Tours</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Bitoun A, Ponchon T, Barthet M, Coffin B, Dugué C, Halphen M; Norcol Group. Results of a prospective randomised multicentre controlled trial comparing a new 2-L ascorbic acid plus polyethylene glycol and electrolyte solution vs. sodium phosphate solution in patients undergoing elective colonoscopy. Aliment Pharmacol Ther. 2006 Dec;24(11-12):1631-42. Epub 2006 Nov 10.</citation>
    <PMID>17094774</PMID>
  </reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2008</study_first_submitted>
  <study_first_submitted_qc>January 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2008</study_first_posted>
  <last_update_submitted>January 29, 2008</last_update_submitted>
  <last_update_submitted_qc>January 29, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 30, 2008</last_update_posted>
  <responsible_party>
    <name_title>Cécile DUGUE Medical Director</name_title>
    <organization>Norgine Pharma</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

